Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients

References

• Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–3785.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Tobinai K, Oguchi M, et al. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. JCO. 2009;27:5594–5600.
   PubMed Web of Science ®Google Scholar
• Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998;9:717–720.
   PubMed Web of Science ®Google Scholar
• Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1998;339:21–26.
   PubMed Web of Science ®Google Scholar
• Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. JCO. 1998;16:70–77.
   PubMed Web of Science ®Google Scholar
• Kim WS, Song SY, Ahn YC, et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol. 2001;12:349–352.
   PubMed Web of Science ®Google Scholar
• Ribrag V, Ell Hajj M, Janot F, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia. 2001;15:1123–1126.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Ogawa S, Nomoto Y, et al. Treatment outcome of nasal NK-cell lymphoma: A report of 12 consecutively-diagnosed cases and a review of the literature. J Clin Exp Hematopathol. 2001;41:93–99.
   Google Scholar
• Aviles A, Neri N, Fernandez R, et al. Combined therapy in untreated patients improves outcome in nasal NK/T lymphoma: results of a clinical trial. Med Oncol. 2013;30:637.
   PubMed Web of Science ®Google Scholar
• Li S, Feng X, Li T, et al. Extranodal NK/T-cell lymphoma, nasal type: a Report of 73 Cases at MD Anderson Cancer Center. Am J Surg Pathol. 2013;37:14–23.
   Google Scholar
• Yamaguchi M, Tobinai K, Oguchi M, et al. Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211. JCO. 2012;30:4044–4046.
   PubMed Web of Science ®Google Scholar
• Deng T, Zhang C, Zhang X, et al. Treatment outcome of radiotherapy alone versus radiochemotherapy in IE/IIE extranodal nasal-type natural killer/T cell lymphoma: a meta-analysis. PLoS One. 2014;9:e106577.
   PubMed Web of Science ®Google Scholar
• Jiang L, Li SJ, Jiang YM, et al. The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysis. Leuk Lymphoma. 2014;55:1038–1048.
   PubMed Web of Science ®Google Scholar
• Khan L, Hodgson D, Sun A, et al. A single institution experience of extranodal natural killer/T cell lymphoma of nasal type. Leuk Lymphoma. 2015;56:80–84.
   PubMed Web of Science ®Google Scholar
• Li YX, Liu QF, Wang WH, et al. Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy. Cancer. 2011;117:5203–5211.
   PubMed Web of Science ®Google Scholar
• Luo J, Liu L, Wu R, et al. Prognostic analysis of 130 patients with nasal and Waldeyer ring NK/T cell lymphoma treated by radiotherapy and/or chemotherapy. Chinese J Radiat Oncol. 2013;22:180–183.
   Google Scholar
• Kim GE, Lee SW, Chang SK, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol. 2001;61:261–269.
   PubMed Web of Science ®Google Scholar
• Tham IW, Lee KM, Yap SP, et al. Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy. Head Neck. 2006;28:126–134.
   PubMed Web of Science ®Google Scholar
• Jiang M, Zhang H, Jiang Y, et al. Phase 2 trial of “sandwich’ L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma”. Cancer. 2012;118:3294–3301.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim K, Kim BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: Consortium for Improving Survival of Lymphoma Study. JCO. 2009;27:6027–6032.
   PubMed Web of Science ®Google Scholar
• Hershman DL, Wright JD, Lim E, et al. Contraindicated use of bevacizumab and toxicity in elderly patients with cancer. JCO. 2013;31:3592–3599.
   PubMed Web of Science ®Google Scholar
• Olver I. Chemotherapy for elderly patients with advanced cancer: is it worth it? Aust Prescr. 2000;23:80–82.
   Google Scholar
• Wang L, Wang ZH, Chen XQ, et al. First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma. Cancer. 2013;119:348–355.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Yang DH, Kim JS, et al. Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study. Ann Hematol. 2014;93:1895–1901.
   PubMed Web of Science ®Google Scholar
• Peh SC. Host ethnicity influences non-Hodgkin's lymphoma subtype frequency and Epstein-Barr virus association rate: the experience of a multi-ethnic patient population in Malaysia. Histopathology. 2001;38:458–465.
   PubMed Web of Science ®Google Scholar
• Shahrokni A, Wu AJ, Carter J, et al. Long-term toxicity of cancer treatment in older patients. Clin Geriatr Med. 2016;32:63–80.
   PubMed Web of Science ®Google Scholar
• Burdette-Radoux S, Muss HB. Adjuvant chemotherapy in the elderly: whom to treat, what regimen?. Oncologist. 2006;11:234–242.
   PubMed Web of Science ®Google Scholar
• Chang CK, Jacobs IA, Vizgirda VM, et al. Melanoma in the elderly patient. Arch Surg. 2003;138:1135–1138.
   PubMedGoogle Scholar
• Samstein RM, Ho AL, Lee NY, et al. Locally advanced and unresectable cutaneous squamous cell carcinoma: outcomes of concurrent cetuximab and radiotherapy. J Skin Cancer. 2014;2014:284582.
   PubMedGoogle Scholar
• Tesarova P. Breast cancer in the elderly-should it be treated differently?. Rep Pract Oncol Radiother. 2012;18:26–33.
   PubMedGoogle Scholar
• Azarpira N, Ashraf MJ, Monabati A, et al. Primary lymphoma of nasal cavity and paranasal sinuses. Lab Med. 2012;43:294–299.
   Web of Science ®Google Scholar
• Kim SJ, Yoon DH, Jaccard A, et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016;17:389–400.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhu Y, Cao JZ, et al. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. Blood. 2015;126:1424–1432.
   PubMed Web of Science ®Google Scholar